Postdocs, patients, administrators were all unmoored by sudden policy shifts.December 11, 2025Check out STAT+Sponsored By Laura Weiler for STAT Postscripts from the frontlines of Trump's attacks on science: no simple happy endings Stories from the front lines of Trump's attack on science: Follow-ups from a year of struggles in Part 7 of our series "American Science, Shattered." By STAT Staff STAT+ | ACA premium spike looms as Senate votes fail, House bill faces long odds Senate rejects both Democratic and Republican proposals on health care as year-end expiration of Affordable Care Act subsidies draws closer. By John Wilkerson STAT+ | Lilly's next-gen obesity drug delivers major weight loss in Phase 3 trial, but with many discontinuations Some participants in the trial discontinued the drug because they were losing too much weight, an emerging concern with obesity medicines. By Elaine Chen Molly Ferguson/STAT STAT+ | Wave's 'gym bro' obesity drug is story over substance Wave is selling a story that is proving irresistible to investors looking for the next big thing in obesity. By Adam Feuerstein ASH 2025 recap: what you need to know from the big medical meeting American Society of Hematology conference serves up latest research to thousands of attendees: Alex Hogan breaks it down in this week's STATus Report. By Alex Hogan STAT+ | Europe's pharma policy shakeup moves forward toward enactment Policymakers unveiled an agreement, which still needs to be voted on, that aims to encourage innovation while improving access to drugs. By Andrew Joseph Go Nakamura/Getty Images Opinion: When a doctor can't heal his friends When a doctor lost two close friends to diseases that couldn't be treated, he learned to see suffering, compassion, and empathy in new ways. By Venktesh Ramnath Opinion: Now is the time to launch mpox vaccine booster trials It's unclear how long the two-dose Jynneos vaccine for mpox offers protection. With cases of mpox clade I in the U.S., we need answers. By Joseph Osmundson and Miguel I. Paredes More around STATCheck out more exclusive coverage with a STAT+ subscriptionRead premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.Enjoying Daily Recap? Tell us about your experienceContinue reading the latest health & science news with the STAT appDownload on the App Store or get it on Google Play STAT, 1 Exchange Place, Boston, MA©2025, All Rights Reserved.I no longer wish to receive STAT emailsUpdate Newsletter Preferences • Contact Us • Advertise with Us • View in Browser
No comments